UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Atlanta Consulting Group Advisors LLC

Atlanta Consulting Group Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 43.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,025 shares of the healthcare conglomerate’s stock after purchasing an additional 919 shares during the period. Atlanta Consulting Group Advisors LLC’s holdings in UnitedHealth Group were worth $1,769,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Price T Rowe Associates Inc. MD increased its holdings in shares of UnitedHealth Group by 0.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares during the period. Bank of New York Mellon Corp raised its position in UnitedHealth Group by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after buying an additional 35,533 shares during the last quarter. International Assets Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the period. Finally, Ameriprise Financial Inc. lifted its holdings in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after acquiring an additional 21,149 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on UNH shares. Stephens decreased their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Stock Performance

NYSE UNH opened at $592.23 on Friday. The stock has a 50-day moving average of $582.84 and a two-hundred day moving average of $549.52. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market cap of $545.02 billion, a P/E ratio of 38.58, a P/E/G ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the company posted $6.56 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.